PATENT CLAIM ANALYSIS

Application Number: 15757354
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "195170"]

Abstract:
The present invention provides a method for inhibiting the UDP-GDH enzyme, which has in itself important beneficial implications, thus strongly enhancing the absorption and circulation of the natural drug curcumin, which in itself is poorly absorbed by the human organism. The method consists in blending curcumin with whole cyanobacterial algae, particularly  Aphanizomenon flos  aquae (but also  Spirulina ) or algal extracts concentrating or purifying the cyanobacterial molecules phycocyanin and phycocyanobilin. The method solves the significant problem of poor curcumin absorption through substances that also add their own nutritional and antioxidant activity to the mix.

Claim (Index 5):
The composition according to  claim 1 , whereby the microalgae is any cyanobacterial microalgae or microalga extract containing phycocyanins and phycocyanobilins.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 90.0
- Lexical Diversity: 1.37838
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12306478', '12306483', '11293565', '13723503', '11072054']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7103271777648441
- 35 USC 102 Novelty (BERT): 0.4969253978265339
- Combined Prediction Score: 0.6889869997710132
- Mean Citation Score: 154.613584
- Max Citation Score: 206.59116
- Similarity Product: 137.7373320801401

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test